Page last updated: 2024-09-05

desmethylselegiline and debrisoquin

desmethylselegiline has been researched along with debrisoquin in 1 studies

Compound Research Comparison

Studies (desmethylselegiline)	Trials (desmethylselegiline)	Recent Studies (post-2010) (desmethylselegiline)	Studies (debrisoquin)	Trials (debrisoquin)	Recent Studies (post-2010) (debrisoquin)
42	12	1	890	89	17

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anttila, M; Bertilsson, L; Dahl, ML; Karnani, H; Nyman, L; Pelkonen, O; Scheinin, H; Taavitsainen, P	1

Trials

1 trial(s) available for desmethylselegiline and debrisoquin

Article	Year
CYP2D6 polymorphism is not crucial for the disposition of selegiline. Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:4 Topics: Adrenergic Agents; Adult; Amphetamines; Area Under Curve; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans; In Vitro Techniques; Male; Methamphetamine; Microsomes, Liver; Monoamine Oxidase Inhibitors; Polymorphism, Genetic; Reference Values; Selegiline	1998

Article

Year

CYP2D6 polymorphism is not crucial for the disposition of selegiline.

Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:4

Topics: Adrenergic Agents; Adult; Amphetamines; Area Under Curve; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans; In Vitro Techniques; Male; Methamphetamine; Microsomes, Liver; Monoamine Oxidase Inhibitors; Polymorphism, Genetic; Reference Values; Selegiline

1998